A carregar...
New Oral Anti-Cancer Drugs and Medication Safety
BACKGROUND: Many oral anti-cancer drugs have come onto the market in the past 20 years. For example, kinase inhibitors, such as the BCR-ABL and BRAF inhibitors, have markedly improved the treatment of chronic myeloid leukemia and melanoma. In this review, we discuss the special challenges posed by p...
Na minha lista:
| Publicado no: | Dtsch Arztebl Int |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Deutscher Arzte Verlag
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935973/ https://ncbi.nlm.nih.gov/pubmed/31920193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2019.0775 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|